|
Fusion gene ID: 37080 |
FusionGeneSummary for TAF15_PTRH2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: TAF15_PTRH2 | Fusion gene ID: 37080 | Hgene | Tgene | Gene symbol | TAF15 | PTRH2 | Gene ID | 8148 | 51651 |
Gene name | TATA-box binding protein associated factor 15 | peptidyl-tRNA hydrolase 2 | |
Synonyms | Npl3|RBP56|TAF2N|TAFII68 | BIT1|CFAP37|CGI-147|IMNEPD|PTH|PTH 2|PTH2 | |
Cytomap | 17q12 | 17q23.1 | |
Type of gene | protein-coding | protein-coding | |
Description | TATA-binding protein-associated factor 2NRBP56/CSMF fusionTAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDaTATA box binding protein (TBP)-associated factor, RNA polymerase II, N, 68kD (RNA-binding protein 56)TATA box-bin | peptidyl-tRNA hydrolase 2, mitochondrialbcl-2 inhibitor of transcription 1cilia and flagella associated protein 37 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q92804 | Q9Y3E5 | |
Ensembl transtripts involved in fusion gene | ENST00000588240, ENST00000592237, ENST00000311979, | ENST00000393038, ENST00000537860, ENST00000409433, ENST00000470557, ENST00000579915, | |
Fusion gene scores | * DoF score | 9 X 7 X 4=252 | 6 X 4 X 5=120 |
# samples | 15 | 7 | |
** MAII score | log2(15/252*10)=-0.748461233004036 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TAF15 [Title/Abstract] AND PTRH2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-BH-A1ES-01A | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000588240 | ENST00000393038 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
In-frame | ENST00000588240 | ENST00000537860 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000588240 | ENST00000409433 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000588240 | ENST00000470557 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
5CDS-intron | ENST00000588240 | ENST00000579915 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000592237 | ENST00000393038 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
In-frame | ENST00000592237 | ENST00000537860 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000592237 | ENST00000409433 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000592237 | ENST00000470557 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
5CDS-intron | ENST00000592237 | ENST00000579915 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000311979 | ENST00000393038 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
In-frame | ENST00000311979 | ENST00000537860 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000311979 | ENST00000409433 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Frame-shift | ENST00000311979 | ENST00000470557 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
5CDS-intron | ENST00000311979 | ENST00000579915 | TAF15 | chr17 | 34151202 | + | PTRH2 | chr17 | 57775339 | - |
Top |
FusionProtFeatures for TAF15_PTRH2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
TAF15 | PTRH2 |
RNA and ssDNA-binding protein that may play specificroles during transcription initiation at distinct promoters. Canenter the preinitiation complex together with the RNA polymeraseII (Pol II). {ECO:0000269|PubMed:19124016}. | The natural substrate for this enzyme may be peptidyl-tRNAs which drop off the ribosome during protein synthesis.{ECO:0000250}. Promotes caspase-independent apoptosis by regulating thefunction of two transcriptional regulators, AES and TLE1.{ECO:0000269|PubMed:15006356}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TAF15_PTRH2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_TAF15_ENST00000588240_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_381aa MSDSGSYGQSGGEQQSYSTYGNPGSQGYGQASQSYSGYGQTTDSSYGQNYSGYSSYGQSQSGYSQSYGGYENQKQSSYSQQPYNNQGQQQ NMESSGSQGGRAPSYDQPDYGQQDSYDQQSGYDQHQGSYDEQSNYDQQHDSYSQNQQSYHSQRENYSHHTQDDRRDVSRYGEDNRGYGGS QGGGRGRGGYDKDGRGPMTGSRCPPNPWLWNIWLIPVHSAWLLELLVACAWAGAFEYALGCSPKARRARHTQILKVKQASWETAGSTRXF LWFEMTXRWEKGKWLPSALMLLFQPTSRFKEEILKCSNNGNTVASPRWWSKLLMKKPXLHYWPMQKCWDXLXVXFKMLDVLRLHQALKLS >In-frame_TAF15_ENST00000592237_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_290aa MESSGSQGGRAPSYDQPDYGQQDSYDQQSGYDQHQGSYDEQSNYDQQHDSYSQNQQSYHSQRENYSHHTQDDRRDVSRYGEDNRGYGGSQ GGGRGRGGYDKDGRGPMTGSRCPPNPWLWNIWLIPVHSAWLLELLVACAWAGAFEYALGCSPKARRARHTQILKVKQASWETAGSTRXFL WFEMTXRWEKGKWLPSALMLLFQPTSRFKEEILKCSNNGNTVASPRWWSKLLMKKPXLHYWPMQKCWDXLXVXFKMLDVLRLHQALKLSX >In-frame_TAF15_ENST00000311979_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_378aa MSDSGSYGQSGGEQQSYSTYGNPGSQGYGQASQSYSGYGQTTDSSYGQNYSGYSSYGQSYSQSYGGYENQKQSSYSQQPYNNQGQQQNME SSGSQGGRAPSYDQPDYGQQDSYDQQSGYDQHQGSYDEQSNYDQQHDSYSQNQQSYHSQRENYSHHTQDDRRDVSRYGEDNRGYGGSQGG GRGRGGYDKDGRGPMTGSRCPPNPWLWNIWLIPVHSAWLLELLVACAWAGAFEYALGCSPKARRARHTQILKVKQASWETAGSTRXFLWF EMTXRWEKGKWLPSALMLLFQPTSRFKEEILKCSNNGNTVASPRWWSKLLMKKPXLHYWPMQKCWDXLXVXFKMLDVLRLHQALKLSXGL |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_TAF15_ENST00000588240_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_1145nt ATGTCGGATTCTGGAAGTTACGGTCAGTCTGGGGGTGAGCAGCAAAGTTATTCTACCTATGGAAATCCAGGCAGCCAAGGCTATGGACAA GCATCACAAAGCTATTCTGGCTATGGGCAAACGACTGATTCCTCTTATGGACAGAACTACAGCGGTTACTCCAGTTATGGACAAAGTCAG TCAGGTTATTCACAGTCCTATGGTGGTTATGAGAATCAAAAGCAGAGCTCATATAGCCAGCAACCATATAATAACCAGGGACAGCAGCAA AACATGGAATCATCAGGAAGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCAACAAGATTCATATGACCAGCAGTCA GGCTATGATCAACATCAAGGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTATAGTCAAAACCAGCAGTCCTATCAT TCACAAAGGGAAAACTACAGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGAAGATAATAGAGGATATGGCGGGTCA CAGGGAGGAGGTAGAGGGCGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAGATGCCCTCCAAATCCTTGGTTATGG AATATTTGGCTCATCCCAGTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGCTGGAGCCTTCGAGTATGCTTTGGGA TGCTCCCCAAAAGCAAGACGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGAGACAGCGGGGAGTACAAGATGATTC TTGTGGTTCGAAATGACTTAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCTGTTTCAGCCTACAAGCAGATTCAAA GAAGAAATCCTGAAATGCTCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCTCCTGATGAAGAAACCCTGATTGCAT TATTGGCCCATGCAAAAATGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAGATTGCACCAGGCTCTCAAACTGTCC >In-frame_TAF15_ENST00000592237_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_872nt ATGGAATCATCAGGAAGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCAACAAGATTCATATGACCAGCAGTCAGGC TATGATCAACATCAAGGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTATAGTCAAAACCAGCAGTCCTATCATTCA CAAAGGGAAAACTACAGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGAAGATAATAGAGGATATGGCGGGTCACAG GGAGGAGGTAGAGGGCGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAGATGCCCTCCAAATCCTTGGTTATGGAAT ATTTGGCTCATCCCAGTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGCTGGAGCCTTCGAGTATGCTTTGGGATGC TCCCCAAAAGCAAGACGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGAGACAGCGGGGAGTACAAGATGATTCTTG TGGTTCGAAATGACTTAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCTGTTTCAGCCTACAAGCAGATTCAAAGAA GAAATCCTGAAATGCTCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCTCCTGATGAAGAAACCCTGATTGCATTAT TGGCCCATGCAAAAATGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAGATTGCACCAGGCTCTCAAACTGTCCTAG >In-frame_TAF15_ENST00000311979_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_1136nt ATGTCGGATTCTGGAAGTTACGGTCAGTCTGGGGGTGAGCAGCAAAGTTATTCTACCTATGGAAATCCAGGCAGCCAAGGCTATGGACAA GCATCACAAAGCTATTCTGGCTATGGGCAAACGACTGATTCCTCTTATGGACAGAACTACAGCGGTTACTCCAGTTATGGACAAAGTTAT TCACAGTCCTATGGTGGTTATGAGAATCAAAAGCAGAGCTCATATAGCCAGCAACCATATAATAACCAGGGACAGCAGCAAAACATGGAA TCATCAGGAAGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCAACAAGATTCATATGACCAGCAGTCAGGCTATGAT CAACATCAAGGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTATAGTCAAAACCAGCAGTCCTATCATTCACAAAGG GAAAACTACAGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGAAGATAATAGAGGATATGGCGGGTCACAGGGAGGA GGTAGAGGGCGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAGATGCCCTCCAAATCCTTGGTTATGGAATATTTGG CTCATCCCAGTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGCTGGAGCCTTCGAGTATGCTTTGGGATGCTCCCCA AAAGCAAGACGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGAGACAGCGGGGAGTACAAGATGATTCTTGTGGTTC GAAATGACTTAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCTGTTTCAGCCTACAAGCAGATTCAAAGAAGAAATC CTGAAATGCTCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCTCCTGATGAAGAAACCCTGATTGCATTATTGGCCC ATGCAAAAATGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAGATTGCACCAGGCTCTCAAACTGTCCTAGGGATTG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_TAF15_ENST00000588240_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_1391nt AGTCCGCCTCAGCCCGCCGCGCCGCCCTCAGTACAGCTCCGGCCGCCGCGCCGCCTGGCTTTCGTATTCGTTGTTCTCGGCGGGCTGTGG GGCCTCCGCGCCGCGGCCGTTAGTCATGTCGGATTCTGGAAGTTACGGTCAGTCTGGGGGTGAGCAGCAAAGTTATTCTACCTATGGAAA TCCAGGCAGCCAAGGCTATGGACAAGCATCACAAAGCTATTCTGGCTATGGGCAAACGACTGATTCCTCTTATGGACAGAACTACAGCGG TTACTCCAGTTATGGACAAAGTCAGTCAGGTTATTCACAGTCCTATGGTGGTTATGAGAATCAAAAGCAGAGCTCATATAGCCAGCAACC ATATAATAACCAGGGACAGCAGCAAAACATGGAATCATCAGGAAGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCA ACAAGATTCATATGACCAGCAGTCAGGCTATGATCAACATCAAGGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTA TAGTCAAAACCAGCAGTCCTATCATTCACAAAGGGAAAACTACAGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGA AGATAATAGAGGATATGGCGGGTCACAGGGAGGAGGTAGAGGGCGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAG ATGCCCTCCAAATCCTTGGTTATGGAATATTTGGCTCATCCCAGTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGC TGGAGCCTTCGAGTATGCTTTGGGATGCTCCCCAAAAGCAAGACGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGA GACAGCGGGGAGTACAAGATGATTCTTGTGGTTCGAAATGACTTAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCT GTTTCAGCCTACAAGCAGATTCAAAGAAGAAATCCTGAAATGCTCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCT CCTGATGAAGAAACCCTGATTGCATTATTGGCCCATGCAAAAATGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAG ATTGCACCAGGCTCTCAAACTGTCCTAGGGATTGGGCCAGGACCAGCAGACCTAATTGACAAAGTCACTGGTCACCTAAAACTTTACTAG GTGGACTTTGATATGACAACAACCCCTCCATCACAAGTGTTTGAAGCCTGTCAGATTCTAACAACAAAAGCTGAATTTCTTCACCCAACT >In-frame_TAF15_ENST00000592237_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_1532nt AGTACAGCTCCGGCCGCCGCGCCGCCTGGCTTTCGTATTCGTTGTTCTCGGCGGGCTGTGGGGCCTCCGCGCCGCGGCCGTTAGTCATGT CGGCGAGGCCTCGGGCCAGTCATCTCGCCGCCTCGTACCTCAGTTTTCCCATCCTCGAAGTGGAGCTGGGCCTGCCTGACTCACCCATTC ATCAGCAAGTCTTTGGAAATATTTTTGTTGGTGCTGACAGCCAAAGCAGTCCAATACAGAGGAATGGTGTATATCTTGGGGTGATTCTGG AAGTTACGGTCAGTCTGGGGGTGAGCAGCAAAGTTATTCTACCTATGGAAATCCAGGCAGCCAAGGCTATGGACAAGCATCACAAAGCTA TTCTGGCTATGGGCAAACGACTGATTCCTCTTATGGACAGAACTACAGCGGTTACTCCAGTTATGGACAAAGTCAGTCAGGTTATTCACA GTCCTATGGTGGTTATGAGAATCAAAAGCAGAGCTCATATAGCCAGCAACCATATAATAACCAGGGACAGCAGCAAAACATGGAATCATC AGGAAGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCAACAAGATTCATATGACCAGCAGTCAGGCTATGATCAACA TCAAGGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTATAGTCAAAACCAGCAGTCCTATCATTCACAAAGGGAAAA CTACAGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGAAGATAATAGAGGATATGGCGGGTCACAGGGAGGAGGTAG AGGGCGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAGATGCCCTCCAAATCCTTGGTTATGGAATATTTGGCTCAT CCCAGTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGCTGGAGCCTTCGAGTATGCTTTGGGATGCTCCCCAAAAGC AAGACGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGAGACAGCGGGGAGTACAAGATGATTCTTGTGGTTCGAAAT GACTTAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCTGTTTCAGCCTACAAGCAGATTCAAAGAAGAAATCCTGAA ATGCTCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCTCCTGATGAAGAAACCCTGATTGCATTATTGGCCCATGCA AAAATGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAGATTGCACCAGGCTCTCAAACTGTCCTAGGGATTGGGCCA GGACCAGCAGACCTAATTGACAAAGTCACTGGTCACCTAAAACTTTACTAGGTGGACTTTGATATGACAACAACCCCTCCATCACAAGTG TTTGAAGCCTGTCAGATTCTAACAACAAAAGCTGAATTTCTTCACCCAACTTAAATGTTCTTGAGATGAAAATAAAACCTATTCCCATGT >In-frame_TAF15_ENST00000311979_chr17_34151202_+_PTRH2_ENST00000537860_chr17_57775339_-_1348nt AGCTCCGGCCGCCGCGCCGCCTGGCTTTCGTATTCGTTGTTCTCGGCGGGCTGTGGGGCCTCCGCGCCGCGGCCGTTAGTCATGTCGGAT TCTGGAAGTTACGGTCAGTCTGGGGGTGAGCAGCAAAGTTATTCTACCTATGGAAATCCAGGCAGCCAAGGCTATGGACAAGCATCACAA AGCTATTCTGGCTATGGGCAAACGACTGATTCCTCTTATGGACAGAACTACAGCGGTTACTCCAGTTATGGACAAAGTTATTCACAGTCC TATGGTGGTTATGAGAATCAAAAGCAGAGCTCATATAGCCAGCAACCATATAATAACCAGGGACAGCAGCAAAACATGGAATCATCAGGA AGCCAAGGTGGAAGAGCACCTTCCTATGACCAGCCAGACTATGGTCAACAAGATTCATATGACCAGCAGTCAGGCTATGATCAACATCAA GGCTCATATGATGAGCAGTCAAATTATGATCAGCAGCATGATTCCTATAGTCAAAACCAGCAGTCCTATCATTCACAAAGGGAAAACTAC AGCCACCACACACAAGATGACCGTCGTGATGTGAGTAGGTATGGAGAAGATAATAGAGGATATGGCGGGTCACAGGGAGGAGGTAGAGGG CGTGGGGGATATGACAAGGATGGAAGAGGTCCTATGACAGGATCAAGATGCCCTCCAAATCCTTGGTTATGGAATATTTGGCTCATCCCA GTACACTCGGCTTGGCTGTTGGAGTTGCTTGTGGCATGTGCCTGGGCTGGAGCCTTCGAGTATGCTTTGGGATGCTCCCCAAAAGCAAGA CGAGCAAGACACACACAGATACTGAAAGTGAAGCAAGCATCTTGGGAGACAGCGGGGAGTACAAGATGATTCTTGTGGTTCGAAATGACT TAAAGATGGGAAAAGGGAAAGTGGCTGCCCAGTGCTCTCATGCTGCTGTTTCAGCCTACAAGCAGATTCAAAGAAGAAATCCTGAAATGC TCAAACAATGGGAATACTGTGGCCAGCCCAAGGTGGTGGTCAAAGCTCCTGATGAAGAAACCCTGATTGCATTATTGGCCCATGCAAAAA TGCTGGGACTGACTGTAAGTTTAATTCAAGATGCTGGACGTACTCAGATTGCACCAGGCTCTCAAACTGTCCTAGGGATTGGGCCAGGAC CAGCAGACCTAATTGACAAAGTCACTGGTCACCTAAAACTTTACTAGGTGGACTTTGATATGACAACAACCCCTCCATCACAAGTGTTTG |
Top |
FusionGenePPI for TAF15_PTRH2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TAF15 | SAFB, PRMT1, TAF7, TAF5, TAF13, TAF11, POLR2C, POLR2G, POLR2E, SF1, KAT2B, POLR2A, HIST2H2AC, HIST1H3A, HIST2H4A, CACNA1A, SIRT7, CUL3, CUL4A, CUL4B, CUL5, CUL2, CUL1, COPS5, COPS6, DCUN1D1, CAND1, NEDD8, DDB1, TPR, SAP30BP, RNF168, SCARB2, TPM2, TMED9, MED26, PRMT8, FUS, RPA3, RPA2, RPA1, HIST3H3, CUL7, OBSL1, EZH2, SUZ12, EED, RNF2, BMI1, RPS6KB2, ACAA2, SFN, HNRNPA1, PPP1CB, MATR3, MED12, MCM2, NF2, DNPEP, KLHL8, TRIM25, BRCA1 | PTRH2 | AES, ATP6V0A1, ATP6V0A2, ATP6V1D, STT3B, FLOT1, RPS2, LAMTOR3, RPS15, JUP, CD55, ABCC2, FLOT2, GADD45GIP1, PTK2, PHYHIP, ARHGEF10, DLK1, FAM63B, TNFRSF10B, CLEC5A, CLTC, COQ9, CHCHD2, DUSP22, DUSP6, DUSP8, DUSP9, EYA3, TLR5, CHRM3, CD7, SLC6A15, HTR2C, SIGLEC10, SLC18A1, HTR3A, SCGB2A2, TEX29, GPR21, YIPF3, HMOX2, SLC39A12, MED21, GRPR, PTPN1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TAF15_PTRH2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TAF15_PTRH2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TAF15 | C0029463 | Osteosarcoma | 1 | CTD_human |
Hgene | TAF15 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | PTRH2 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | PTRH2 | C4015728 | NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET | 1 | ORPHANET;UNIPROT |